Features | Partner Sites | Information | LinkXpress
Sign In
ElsMed
Schiller
Agfa Healthcare

Predicting Heart Attack Risk with CT Angiography

By Medimaging International staff writers
Posted on 25 Feb 2013
Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of myocardial infarctions and other abnormal cardiac events in patients with suspected coronary artery disease (CAD) but no treatable risk factors, such as high blood pressure or high cholesterol.

“CCTA should be considered as an appropriate first-line test for patients with atypical chest pain and suspected but not confirmed coronary artery disease,” said the study’s lead author, Jonathon Leipsic, MD, FRCPC, from the University of British Columbia (Vancouver, BC, Canada).

Treatment for heart disease typically involves tackling modifiable cardiovascular risk factors such as high blood pressure, elevated cholesterol, diabetes, and smoking. However, some risk factors, such as family history, are not modifiable, and no risk models exist to help guide clinicians to identify those symptomatic patients without cardiac risk factors who are at an increased risk of death and myocardial infarction. “This scenario, where patients are symptomatic but have no cardiac risk factors, comes up often in clinical practice,” Dr. Leipsic said. “We lack a good tool to stratify these patients into risk groups.”

CCTA is a noninvasive test that has shown high accuracy for the diagnosis or exclusion of coronary artery disease in individuals. However, referral for patients with suspected coronary artery disease is frequently based on clinical risk factor scoring. Less is known about the prognostic benefits of CCTA in individuals with no medically modifiable risk factors.

In the first study of its sort, published online February 2013 in the journal Radiology, Dr. Leipsic and colleagues correlated CCTA results with the risk of major adverse cardiac events in 5,262 patients with suspected coronary artery disease but no medically modifiable risk factors. They culled the data from the Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter (CONFIRM) registry.

After a median follow-up of 2.3 years, 104 patients had experienced a major adverse cardiovascular event. The researchers identified a high occurrence of CAD in the study group, in spite of the lack of modifiable risk factors. More than 25% of the patients had non-obstructive disease or disease related to the accumulation of plaque in the arteries, and another 12% had obstructive disease with a greater than 50% narrowing in a coronary artery. “We found that patients with narrowing of the coronary arteries on CT had a much higher risk of an adverse cardiac event,” Dr. Leipsic said. “This was true even for those without a family history of heart disease.”

Both asymptomatic and symptomatic patients with obstructive disease faced an increased risk for a major cardiac event. Contrarily, the absence of CAD on CCTA was associated with a very low risk of a major event.

The findings, according to the investigators, emphasize the need for improvement in the evaluation of individuals who may be overlooked by conventional techniques of CAD assessment. “If a patient shows up with vague symptoms and no medically modifiable risk factors, doctors often dismiss them or do a treadmill test, which won’t identify atherosclerosis and only has a modest sensitivity for detecting obstructive disease,” Dr. Leipsic said.

CCTA could help address this problem, Dr. Leipsic added, by helping to detect or rule out coronary artery disease and identifying those who may be helped with more intensive therapy. The researchers continue to examine the CONFIRM data with the goal of further clarifying the association between plaque and myocardial infarctions and the longer-term outlook for patients with coronary artery disease.

“We are now collecting data to determine the prognostic value of CCTA after five years or more of follow-up, which will be very important for the field,” Dr. Leipsic stated.

Related Links:
University of British Columbia



Channels

MRI

view channel
Image: In a preterm infant’s brain, an MRI scan can reveal abnormalities that were undetected by previous methods. The scans on the left show normal gray matter, while those on the right show abnormal gray matter (Photo courtesy of Washington University in St. Louis).

MRI Tracks Infant Brain Growth in First Months of Life

For the first time, researchers have used magnetic resonance imaging (MRI) of the newborn brain to calculate the volume of multiple brain regions and to map out regional growth trajectories during the... Read more

Ultrasound

view channel
Image: Fig. 1a and Fig. 1b depict the guided signals in the intact and fractured long bones, respectively. These images shows an (a) intact and (b) 1-mm width 100% depth fracture (Photo courtesy of Science China Press).

Quantitative Ultrasound Shown to Optimize Assessment of Long Bone Fracture

Research has revealed that mode conversion of ultrasonic-guided waves can quantitatively indicate the fracture degree of long cortical bone, which may provide a new way of evaluating long bone fracture... Read more

Nuclear medicine

view channel

PET/CT Using FDG-Labeled Leukocytes Detects Infection in Acute Pancreatitis Patients

A study out of India that identifies infection in patients with pancreatic fluid collections may rapidly and effectively rule out active infection in the body. This treatment may help in making nuclear medicine imaging a mainstay in clinical management practices. Acute pancreatitis (AP) is an abrupt inflammation of the pancreas.... Read more

General/Advanced Imaging

view channel

Diagnostic Imaging Tests Ordered by General Practitioners in Australia Nearly Double in 10 Years

A 45% increase in diagnostic imaging tests ordered by Australian general practitioners (GPs) is being fueled by increasing GP visits, an escalating number of problems managed at doctor visits, and a higher probability that GPs order imaging tests for these problems, according to a new study. Based on a long-term national... Read more

Imaging IT

view channel
Image: An X-ray using the ClearRead bone suppression software technology (Photo courtesy of Riverain Technologies).

Bone Suppression Software Used to Optimize Diagnostic Capability of X-Ray Systems

Clinicians are gathering important information from the most routine imaging exam, the chest X-ray, by using advanced software that enhances X-ray images captured by the equipment they already have or... Read more

Industry News

view channel

Acquisition Includes Radiation Simulation Software for Radiotherapy Applications

Varian Medical Systems, Inc. (Palo Alto, CA, USA) has acquired certain assets of Transpire, Inc. (Gig Harbor, WA, USA) including the Acuros dose calculation software, which has been incorporated into Varian’s BrachyVision and Eclipse treatment planning software systems. The acquisition closed at the end of July 2014.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.